Trial Outcomes & Findings for SCP® Observational Study of the Knee (NCT NCT03110224)

NCT ID: NCT03110224

Last Updated: 2025-10-28

Results Overview

Change from baseline score of pain intensity at 12 months. To collect VAS, patients marked a slash on a 10 cm horizontal line, with 0 cm indicating "no pain" and 10 cm indicating "worst possible pain." The distance from the left end of the line to the patient's mark was measured by the administrator in centimeters. Lower numbers were representative of lower pain levels.

Recruitment status

TERMINATED

Target enrollment

516 participants

Primary outcome timeframe

12 months

Results posted on

2025-10-28

Participant Flow

Of 516 patients enrolled, 508 had data entered that could be used for analysis.

Participant milestones

Participant milestones
Measure
Subchondroplasty
Patients who were to undergo Subchondroplasty
Overall Study
STARTED
516
Overall Study
COMPLETED
133
Overall Study
NOT COMPLETED
383

Reasons for withdrawal

Reasons for withdrawal
Measure
Subchondroplasty
Patients who were to undergo Subchondroplasty
Overall Study
Death
3
Overall Study
Lost to Follow-up
132
Overall Study
Physician Decision
2
Overall Study
Site Closed by Physician
35
Overall Study
Site Closed by Sponsor
202
Overall Study
Withdrawal by Subject
9

Baseline Characteristics

2 patients did not have age entered at baseline

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Baseline
n=516 Participants
Demographics of patients enrolled in the study.
Age, Categorical
<=18 years
0 Participants
n=514 Participants • 2 patients did not have age entered at baseline
Age, Categorical
Between 18 and 65 years
299 Participants
n=514 Participants • 2 patients did not have age entered at baseline
Age, Categorical
>=65 years
215 Participants
n=514 Participants • 2 patients did not have age entered at baseline
Age, Continuous
Age
56.77 years
STANDARD_DEVIATION 12.63 • n=514 Participants • 2 patients did not have age entered at baseline.
Sex: Female, Male
Female
272 Participants
n=508 Participants • Gender not entered for 8 patients
Sex: Female, Male
Male
236 Participants
n=508 Participants • Gender not entered for 8 patients
Region of Enrollment
United States
516 Participants
n=516 Participants
BMI
31.53 kg/m2
STANDARD_DEVIATION 6.71 • n=504 Participants • BMI could not be calculated for 12 patients due to missing weight, height, or both.

PRIMARY outcome

Timeframe: 12 months

Population: Visual Analog Scale was analyzed at baseline to 12 months.

Change from baseline score of pain intensity at 12 months. To collect VAS, patients marked a slash on a 10 cm horizontal line, with 0 cm indicating "no pain" and 10 cm indicating "worst possible pain." The distance from the left end of the line to the patient's mark was measured by the administrator in centimeters. Lower numbers were representative of lower pain levels.

Outcome measures

Outcome measures
Measure
Primary Outcome Measure
n=250 Participants
Visual Analog Scale measured at baseline and 12 months.
Change From Baseline Visual Analog Scale (VAS) Pain Scale at 12 Months
Baseline
6.8 score on a scale
Interval 6.6 to 7.0
Change From Baseline Visual Analog Scale (VAS) Pain Scale at 12 Months
12 Months
3.6 score on a scale
Interval 3.3 to 4.0

SECONDARY outcome

Timeframe: 5 years

Summary and description of procedure and device related adverse events and surgical re-operations and relatedness to the bone substitute material and procedure

Outcome measures

Outcome measures
Measure
Primary Outcome Measure
n=508 Participants
Visual Analog Scale measured at baseline and 12 months.
Occurences and Severity of Device and/or Procedure Related Adverse Events and Re-visions/Re-operations
Events Related to SCP
36 Number of Events Reported
Occurences and Severity of Device and/or Procedure Related Adverse Events and Re-visions/Re-operations
Events Unrelated to SCP
72 Number of Events Reported
Occurences and Severity of Device and/or Procedure Related Adverse Events and Re-visions/Re-operations
Revisions
72 Number of Events Reported

Adverse Events

Adverse Events

Serious events: 83 serious events
Other events: 17 other events
Deaths: 3 deaths

Serious adverse events

Serious adverse events
Measure
Adverse Events
n=516 participants at risk
Adverse Events reported during the study.
Musculoskeletal and connective tissue disorders
Chondrosis: Patella and Medial Femoral Condyle
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Complex tear of medial meniscus of right knee
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Extensive chondrosis medial femoral condyle and medial tibial plateau
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
General disorders
Fall
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Increased grinding and retropatellar pain
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Infected right knee
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Known patellar chondrosis with recurrent effusions and pain
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Osteoarthritis
9.1%
47/516 • Number of events 49 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Osteoarthritis with fracture
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Persistence of patellofemoral pain not responsive to conservative management.
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Post-operative pain
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Blood and lymphatic system disorders
Right Femoral Popliteal DVT
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Septic Knee
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Subchondral edema/stress fracture reaction medial femoral condyle and medial tibial plateau
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Respiratory, thoracic and mediastinal disorders
Pneumonia
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Left knee draining sinus
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Abdominal pain secondary to pancreatic cancer stage 2 A
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Avascular necrosis
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Bone marrow lesion in femur
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
General disorders
Cephalgia
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Complete tear of medial and lateral menisci
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Increased Knee Pain
2.1%
11/516 • Number of events 11 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
L4-5 Laminectomy w posterior fusion O-arm
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Gastrointestinal disorders
Laparoscopic sleeve gastrectomy w PEH repair for morbid obesity BMI 45.0-49.9
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Left shoulder scope w rotator cuff repair
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Parapatellar increased synovium and scar
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Persistently symptomatic chondral defect of patella
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Persistently symptomatic patellar cartilage defect
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Persistently symptomatic patellar chondrosis
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Eye disorders
Right Eye Cataract
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Right Knee arthroscopy (non study knee)
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Rotator cuff injury
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Total knee arthroplasty
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years

Other adverse events

Other adverse events
Measure
Adverse Events
n=516 participants at risk
Adverse Events reported during the study.
Gastrointestinal disorders
Acute Cholecystitis
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Arthroscopic Surgery
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Difficulty with dorsiflexion of left foot.
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Increased Knee Pain
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Left elbow pain
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Left knee draining sinus
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Left knee stress fracture lateral femoral condyle and impending OCD lesion
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Medial femoral condyle insufficiency fracture
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Osteoarthritis
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
General disorders
Patient had signs of delirium postoperatively
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Right knee chondromalacia patella with right thigh muscle/tendon strain.
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Stress fracture left foot
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Gastrointestinal disorders
GI virus
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Patient reported knee popping with pain
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Cardiac disorders
Supraventricular tachycardia
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Total knee arthroplasty
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years
Musculoskeletal and connective tissue disorders
Unicompartment knee replacement
0.19%
1/516 • Number of events 1 • Surgery, 6 weeks, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years

Additional Information

Annette Tieu

Zimmer Biomet

Phone: 971-482-9622

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place